Newly reported hemophilic C-domain missense mutations
Exon . | Mutations (no. families) . | Factor VIII (% normal) . | Phenotype (severity) . | ||
---|---|---|---|---|---|
VIII:C . | VIII:Ag . | VIII-vWF . | |||
C1 domain | |||||
22 | Q2087E† | 11 | 11 | 1 | Mild |
22 | R2090C† | 14 | 107 | 2 | Mild |
23 | R2150C† (3) | 33 | 30 | <1 | Mild |
23 | R2159C (2) | 20 | 104 | <1 | Mild |
23 | R2163C | 1 | 1 | <1 | Moderate |
23 | M2164R† | 2 | 2 | 3 | Moderate |
C2 domain | |||||
24 | S2173I† (3) | 16 | 41 | 14 | Mild |
24 | A2201P† | 7 | 36 | 1 | Mild |
25 | V2232A† | 9 | 8 | 2 | Mild + Inh |
26 | P2300L (2) | 18 | 18 | 5 | Mild + Inh |
26 | R2304C (3) | 2 | 3 | 2 | Mod + Inh |
26 | R2304G† | 8 | 3 | <1 | Moderate |
26 | R2307Q | 10 | 10 | <1 | Mild |
26 | R2320T† | 5 | 20 | 100 | Moderate |
Exon . | Mutations (no. families) . | Factor VIII (% normal) . | Phenotype (severity) . | ||
---|---|---|---|---|---|
VIII:C . | VIII:Ag . | VIII-vWF . | |||
C1 domain | |||||
22 | Q2087E† | 11 | 11 | 1 | Mild |
22 | R2090C† | 14 | 107 | 2 | Mild |
23 | R2150C† (3) | 33 | 30 | <1 | Mild |
23 | R2159C (2) | 20 | 104 | <1 | Mild |
23 | R2163C | 1 | 1 | <1 | Moderate |
23 | M2164R† | 2 | 2 | 3 | Moderate |
C2 domain | |||||
24 | S2173I† (3) | 16 | 41 | 14 | Mild |
24 | A2201P† | 7 | 36 | 1 | Mild |
25 | V2232A† | 9 | 8 | 2 | Mild + Inh |
26 | P2300L (2) | 18 | 18 | 5 | Mild + Inh |
26 | R2304C (3) | 2 | 3 | 2 | Mod + Inh |
26 | R2304G† | 8 | 3 | <1 | Moderate |
26 | R2307Q | 10 | 10 | <1 | Mild |
26 | R2320T† | 5 | 20 | 100 | Moderate |
Bold Ag levels indicate dysfunctional protein; bold vWF levels, bound Ag, where significantly different from total Ag; Inh, high titer inhibitor in at least one of the reported patients with this mutation.
Factor VIII determined in patient plasma as clotting activity (VIII:C), total factor VIII antigen (VIII:Ag), or vWF-bound factor VIII antigen (VIII-vWF) and reported as percentage of clotting reactivity in a pool of normal donor plasmas.
Novel mutation, not previously reported in database.15